Saturday, May 04, 2002

What's the Buzz?


Sell-off sends Kendle into slide

By James Pilcher jpilcher@enquirer.com
The Cincinnati Enquirer

        Cincinnati-based clinical testing company Kendle International Inc.'s stock price plunged Friday after a sell-off that was sparked when two key analysts downgraded the stock following Thursday's first-quarter earnings report.

        The stock dropped 18.3 percent Friday, a day after Kendle announced its first-quarter earnings. It closed at $12.18, with nearly 200,000 shares changing hands, a 52-week high. It had been trading at nearly $17 a share as recently as Tuesday.

        According to Bloomberg News, Prudential Securities analyst Eric W. Coldwell downgraded the stock from “buy” to “hold,” lowering the stock's target price from $25 to $18 a share. And David H. Windley of Jefferies & Co. cut the stock from “accumulate” to “hold,” lowering the stock's target price from $25 a share to $15.

        Thursday, the company reported $2.1 million in net income, or 17 cents a share, up from just $262,000 in profits, or 2 cents a share, during the same period last year. But in its earnings report, Kendle said that it had $181 million in advance orders and verbal commitments, less than at this same time last year, when it had $185 million.

        Have a tip? Call 768-8147 or e-mail business@enquirer.com.

       



P&G to 'restage' Clairol brand
New day for Sunny Delight?
5/3 Day energized by Welch speech
Jobless rate hits 6 percent
HIGGINS: Hands-off approach to investing
Transfer IRA if it's inherited
Small-cap companies bask in market boom
Rate report
Stop hiding those stock options, Greenspan says
- What's the Buzz?
Tristate Earnings Reports
Tristate Summary
TRW voters block bid
Kmart to review management